CTI Learners’ Questionnaire Cellular Therapy and Immunotherapy Conference 2024November 14-17, 2024Hangzhou, China Step 1 of 2 50% Dear 2024 CTI Participant, In order to receive your EBAH-CME accreditation points for attending the Cellular Therapy and Immunotherapy Conference 2024, November 14-17, 2024, Hangzhou, China, please complete the following learner’s questionnaire. Should you have any questions, please contact: [email protected], or [email protected]. Many thanks, The IACH Secretariat on behalf of the CTI Conference Organization 1. This event has fulfilled my educational goals and my expected learning outcomes 5 – Agree 4 3 – Neutral 2 1 – Disagree 2. I have learned information at this event that will help me to improve my practice 5 – Agree 4 3 – Neutral 2 1 – Disagree 3. The education provided at this event consistently was very good or excellent 5 – Agree 4 3 – Neutral 2 1 – Disagree 4. There was sufficient time for discussions, questions & answers and learner engagement 5 – Agree 4 3 – Neutral 2 1 – Disagree 5. The information presented consistently was supported by a valid scientific evidence base 5 – Agree 4 3 – Neutral 2 1 – Disagree 6. The speakers consistently were very good or excellent 5 – Agree 4 3 – Neutral 2 1 – Disagree 7. There was no bias in any of the programmed educational events 5 – Agree 4 3 – Neutral 2 1 – Disagree Comments:PROGRAM EVALUATION:L1 = Plenary Session and Young ForumFriday – November 15th Did you attend this session? Yes No Youth Forum Comments:Plenary Session Comments:L3 = Cell Research: Advances in Immune Cell TherapyFriday – November 15th Did you attend this session? Yes No Basic Session I:Basic Session II:IACH 1: Cellular Therapy and ImmunotherapySaturday – November 16th Did you attend this session? Yes No Oral Session 1 Comments:Oral Session 2 Comments:IACH 2: Cellular Therapy and Hematology & Stem Cell TransplantationSaturday – November 16th Did you attend this session? Yes No Oral Session 1 Comments:Oral Session 2 Comments:L3 – Hematopoiesis and ImmunotherapySaturday – November 16th Did you attend this session? Yes No Basic Session III Comments:Basic Session IV Comments:IACH 3: Cellular Therapy and Innovative therapy for hematological malignanciesSaturday – November 16th Did you attend this session? Yes No Oral Session 1 Comments:Oral Session 2 Comments:ACTO 1: Immune & Cell Therapy – Asian ReportSaturday – November 16th Did you attend this session? Yes No Oral Session 1 Comments:Oral Session 2 Comments:ACTO 2: Regenerative therapy and gene therapy / Regulatory Session and SCTSaturday – November 16th Did you attend this session? Yes No Oral Session 1 Comments:Oral Session 2 Comments:L1 – CAR T and ImmunotherapySunday – November 17th Did you attend this session? Yes No Plenary Session Comments:Panel Discussion Comments:L3 – Cell Research: Systemic Immunology and OncologySunday – November 17th Did you attend this session? Yes No Basic Session V Comments:Basic Session VI Comments: Personal InformationConsent(Required) I hereby confirm the completed form is correct and that I actively attended the 2024 CTI Conference scientific sessions as marked herein:(Required)Date(Required) MM slash DD slash YYYY SignatureTitle(Required)First name(Required)Last name(Required)Country of origin(Required)Please selectAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland IslandsEBAH Member number(Required)Email address(Required)